Bryant Furlow
Bryant Furlow publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics, on topics such as Cancer Immunotherapy and Biomarkers, Economic and Financial Impacts of Cancer and Lung Cancer Treatments and Mutations.
- World rank
- #7,708,112 of 7,710,434 ranked researchers
- Rank in United States
- #1,626,419 of 1,627,098
- Works
- 706
- Citations
- 1.3k
- Citations per work
- 1.8
What does Bryant Furlow research?
Bryant Furlow's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (10%), Economics, Econometrics and Finance (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else37152.5%
- Health Sciences20829.4%
- Medicine20829.4%
- Life Sciences7210.2%
- Social Sciences567.9%
- 1Oncology13% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Economics and Econometrics8% of their works
- 4Molecular Biology6% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Cancer Research5% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Economic and Financial Impacts of Cancer
- Lung Cancer Treatments and Mutations
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Genomics and Diagnostics
- Science, Research, and Medicine
- Chronic Lymphocytic Leukemia Research
- Prostate Cancer Treatment and Research
Which keywords describe Bryant Furlow's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Genomic Profiling, Immune Checkpoint Blockade, PD-1 and PD-L1, Cost of Care, Financial Toxicity and ALK Inhibitors.
- Androgen Receptor
- Chronic Lymphocytic Leukemia
- Biomedical Science
- Cancer Genomics
- EGFR Mutations
- ALK Inhibitors
- Cost of Care
- Immune Checkpoint Blockade
- Clinical Trials
- Targeted Therapy
- Genomic Profiling
- PD-1 and PD-L1
- Financial Toxicity
- Cost-effectiveness Analysis
- Quality of Life
- Mutational Signatures
- Health Research
- Genomic Aberrations
- Prostate Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Targeted Therapy802 topics
- Clinical Trials712 topics
- Genomic Profiling712 topics
- Immune Checkpoint Blockade571 topic
- PD-1 and PD-L1571 topic
- Cost of Care521 topic
- Financial Toxicity521 topic
- ALK Inhibitors421 topic
- Cost-effectiveness Analysis421 topic
- EGFR Mutations421 topic
- Quality of Life421 topic
- Cancer Genomics381 topic
- Mutational Signatures381 topic
- Biomedical Science341 topic
- Health Research341 topic
- Chronic Lymphocytic Leukemia301 topic
- Genomic Aberrations301 topic
- Androgen Receptor291 topic
- Prostate Cancer291 topic
Where does Bryant Furlow work?
Bryant Furlow's main affiliation in the publication record is University of New Mexico, United States.
How many publications and citations does Bryant Furlow have?
OpenAlex counts 706 works and 1,274 citations for Bryant Furlow, an h-index of 14, ranking #7,708,112 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bryant Furlow. Posts are plain text and can be reported.